ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 97 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $25,588 | -11.7% | 12,605 | 0.0% | 0.02% | +4.8% |
Q2 2023 | $28,992 | -24.1% | 12,605 | 0.0% | 0.02% | -34.4% |
Q1 2023 | $38,193 | +30.0% | 12,605 | 0.0% | 0.03% | +28.0% |
Q4 2022 | $29,370 | +22.4% | 12,605 | 0.0% | 0.02% | +13.6% |
Q3 2022 | $24,000 | -29.4% | 12,605 | 0.0% | 0.02% | -24.1% |
Q2 2022 | $34,000 | – | 12,605 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COWEN AND COMPANY, LLC | 4,331,020 | $7,882,000 | 1.31% |
RTW INVESTMENTS, LP | 6,869,281 | $12,502,000 | 0.35% |
A.R.T. Advisors, LLC | 14,140 | $26,000 | 0.04% |
Hudson Bay Capital Management LP | 975,000 | $1,774,000 | 0.03% |
Secure Asset Management, LLC | 10,000 | $18,000 | 0.01% |
OSAIC HOLDINGS, INC. | 1,774,935 | $3,230,000 | 0.01% |
FNY Investment Advisers, LLC | 9,900 | $18,000 | 0.01% |
Squarepoint Ops LLC | 322,225 | $586,000 | 0.01% |
LMR Partners LLP | 107,912 | $196,000 | 0.01% |
Virtu Financial LLC | 17,147 | $31,000 | 0.00% |